Cancer Research UK has announced a new trial that aims to investigate the risks associated with spending time in the sun.
The project will use simulated sunlight in a bid to identify whether particular amounts of sun are advantageous for specific skin types, and look at how much qualifies as being excessive.
Study leader professor Lesley Rhodes from the University of Manchester said: " There’s no doubt that too much sun can seriously increase skin cancer risk, but we know there are also important benefits to going out in the sun, such as making enough vitamin D."
The clinical research expert added that the findings aim to determine advice that is applicable to people of all skin colours.
News of the organisation's project comes after Cancer Research UK funded work at the Institute of Cancer Research in London, which indicated that the experimental drug AT13148 could be used as a master switch in order to block cancerous enzymes